1. HDAC1,2 Knock-Out and HDACi Induced Cell Apoptosis in Imatinib-Resistant K562 Cells
   Shu-Huey Chen et al, 2019, International Journal of Molecular Sciences CrossRef
2. A combined computational and experimental strategy identifies mutations conferring resistance to drugs targeting the BCR-ABL fusion protein
   Jinxin Liu et al, 2020, Communications Biology CrossRef
3. The effects of cannabidiol via TRPV2 channel in chronic myeloid leukemia cells and its combination with imatinib
   Federica Maggi et al, 2022, Cancer Science CrossRef
4. CAY10683 and imatinib have synergistic effects in overcoming imatinib resistance via HDAC2 inhibition in chronic myeloid leukemia
   Tianzhuo Zhang et al, 2020, RSC Advances CrossRef
5. Homoharringtonine enhances the effect of imatinib on chronic myelogenous leukemia cells by downregulating ZFX
   Jingjing Wu et al, 2019, Molecular Medicine Reports CrossRef
6. BCR-ABL triggers a glucose-dependent survival program during leukemogenesis through the suppression of TXNIP
   Lin Feng et al, 2023, Cell Death & Disease CrossRef
7. Targeted blocking of miR328 lysosomal degradation with alkalized exosomes sensitizes the chronic leukemia cells to imatinib
   Yan Dong et al, 2019, Applied Microbiology and Biotechnology CrossRef
8. Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining
   Nikola Curik et al, 2021, Frontiers in Oncology CrossRef